Antibody Dependent Enhancement (ade) - Vaccines

Relevant Publications

Antiviral activity of extract against feline coronavirus .

Issue Release: 2024

Within-host models unravelling the dynamics of dengue reinfections.

Issue Release: 2024

Super epitope dengue vaccine instigated serotype independent immune protection in-silico.

Issue Release: 2024

NS1: a promising novel target antigen with strong immunogenicity and protective efficacy for avian flavivirus vaccine development.

Issue Release: 2024

An Engineered N-Glycosylated Dengue Envelope Protein Domain III Facilitates Epitope-Directed Selection of Potently Neutralizing and Minimally Enhancing Antibodies.

Issue Release: 2024

Antibody-dependent enhancement (ADE) of SARS-CoV-2 in patients exposed to MERS-CoV and SARS-CoV-2 antigens.

Issue Release: 2024

Predicting immune response targets in orthoflaviviruses through sequence homology and computational analysis.

Issue Release: 2024

Functional genomics screens reveal a role for TBC1D24 and SV2B in antibody-dependent enhancement of dengue virus infection.

Issue Release: 2024

Exacerbated lung inflammation in offspring with high maternal antibody levels following secondary RSV exposure.

Issue Release: 2024

Preclinical assessment of a recombinant RBD-Fc fusion protein as SARS-CoV-2 candidate vaccine.

Issue Release: 2024

From Detection to Protection: Antibodies and Their Crucial Role in Diagnosing and Combatting SARS-CoV-2.

Issue Release: 2024

Functional genomics screens reveal a role for TBC1D24 and SV2B in antibody-dependent enhancement of dengue virus infection.

Issue Release: 2024

Preclinical Development of a Novel Zika Virus-like Particle Vaccine in Combination with Tetravalent Dengue Virus-like Particle Vaccines.

Issue Release: 2024

An In Silico Design of a Vaccine against All Serotypes of the Dengue Virus Based on Virtual Screening of B-Cell and T-Cell Epitopes.

Issue Release: 2024

A single-dose circular RNA vaccine prevents Zika virus infection without enhancing dengue severity in mice.

Issue Release: 2024

Antibody-dependent enhancement and neutralization against CVB4 investigated in vitro and in silico through an agent-based model.

Issue Release: 2024

No evidence for enhanced disease with human polyclonal SARS-CoV-2 antibody in the ferret model.

Issue Release: 2024

The antibodies against the A137R protein drive antibody-dependent enhancement of African swine fever virus infection in porcine alveolar macrophages.

Issue Release: 2024

Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infection.

Issue Release: 2024

C1q modulation of antibody dependent enhancement of dengue virus infection in human myeloid cell lines is dependent on cell type and antibody specificity.

Issue Release: 2024

What Role Do Vaccines Play in Public Health?

What is Poliovirus?

Who Can Report to VAERS?

Who Can Administer Vaccines?

Can Vaccines Cause Heart Failure?

Why is Vaccine Access Important?

Why is a Vaccine for Hepatitis C Important?

What Should Heart Failure Patients Consider Before Getting Vaccinated?

Are There Any Contraindications to Vaccination?

What are mRNA Vaccines?

Partnered Content Networks

Relevant Topics